Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Fisher A, Andreasson A, Chrysos A, et al. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK. Southampton (UK): NIHR Journals Library; 2016 Nov. (Health Technology Assessment, No. 20.85.)
An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
Show detailsTABLE 51
Resource or intervention | Unit | Patient details | Mean usage in standard donor lung transplantation | Mean usage in EVLP transplantation | Resource source |
---|---|---|---|---|---|
Donor’s hospital | |||||
Fixed costs | |||||
Initial assessment | |||||
ABG | Test | Donor | 1.00 | 1.00 | CRF p. 23/Anne Davison, NuTH, June 2015, personal communication |
Bronchoscopy | Procedure | Donor | 1.00 | 1.00 | Paul Henderson, NuTH, September 2014, personal communication/Katharine Thornalley, NuTH, June 2015, personal communication |
Chest X-ray (radiography) | Test | Donor | 1.00 | 1.00 | CRF p. 23/Anne Davison, NuTH, June 2015, personal communication |
ECG | Test | Donor | 1.00 | 1.00 | Anne Davison, NuTH, June 2015, personal communication |
FBC | Test | Donor | 1.00 | 1.00 | Anne Davison, NuTH, June 2015, personal communication |
Drugs | |||||
Methylprednisolone (as sodium succinate) | 500-mg vial | Donor | 1.00 | 1.00 | CRF p. 25 |
Methylprednisolone (as sodium succinate) | 1-g vial | Donor | 1.00 | 1.00 | CRF p. 25/Tanveer Butt, NuTH, June 2015, personal communication |
Methylprednisolone (as sodium succinate) | 2-g vial | Donor | 1.00 | 1.00 | CRF p. 25 |
Lung retrieval | |||||
Fixed costs | |||||
Equipment | |||||
DCD donor | |||||
Bronchoscope | Instrument | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Pink spray 0.5% chlorhexidine | Spray | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
2 l of 0.9% sodium chloride solution | 1-l solution | Donor | 16.00 | 16.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Strapple tape | Roll | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
DBD donor | |||||
Blue 23-gauge 25-mm (1-inch) needles | 1-inch needle | Donor | 5.00 | 5.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Bronchoscope | Instrument | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
1-l cardioplegia bag (green PLEGIVEX) | 1-l bag | Donor | 3.00 | 3.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Green vacutainers | Vacutainer | Donor | 6.00 | 6.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
i-STAT portable clinical analyser (Abbott Laboratories, Chicago, IL, USA) | Device | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
i-STAT cartridges | Cartridge | Donor | 8.00 | 8.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Pink spray 0.5% chlorhexidine | Spray | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
1-l pressure infusion bag | 1-l bag | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Red vacutainers | Vacutainer | Donor | 6.00 | 6.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Sodium bicarbonate 8.4% | 10-ml ampoule | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
2 l of 0.9% sodium chloride solution | 1-l solution | Donor | 20.00 | 20.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Spleen pots | Pot | Donor | 6.00 | 6.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Strapple tape | Roll | Donor | 1.00 | 1.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
1-ml syringes | 1-ml syringe | Donor | 5.00 | 5.00 | Retrieval team/Paul Henderson, NuTH, September 2014, personal communication |
Staff time | |||||
Scout Team | |||||
Retrieval surgeon (fellow) | Hour | Donor | 0.80 | 0.80 | Tanveer Butt, NuTH, June 2015, personal communication |
Scrub nurse (band 5) | Hour | Donor | 0.80 | 0.80 | Tanveer Butt, NuTH, June 2015, personal communication |
Retrieval team | |||||
Perfusionist (band 7) | Hour | Donor | 9.00 | 9.00 | Tanveer Butt, NuTH, June 2015, personal communication/Paul Henderson, NuTH, September 2014, personal communication |
Retrieval surgeon (fellow) | Hour | Donor | 9.00 | 9.00 | Tanveer Butt, NuTH, June 2015, personal communication/Paul Henderson, NuTH, September 2014, personal communication |
Scrub nurse (band 5) | Hour | Donor | 9.00 | 9.00 | Tanveer Butt, NuTH, June 2015, personal communication/Paul Henderson, NuTH, September 2014, personal communication |
Tests | |||||
Chest X-ray (radiography) | Test | Donor | 1.00 | 1.00 | CRF p. 23/Anne Davison, NuTH, June 2015, personal communication |
Perfusion (dosage) | |||||
2.8 l of PERFADEX solution | 2.8-l solution | Donor | 1.00 | 1.00 | CRF p. 27/Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
1 l of PERFADEX solution | 1-l solution | Donor | 1.00 | 1.00 | CRF p. 27/Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Calcium chloride 1 mmol/ml (1.7 ml/2.8 l PERFADEX and 0.6 ml/1 l PERFADEX) | 10-ml ampoule | Donor | 1.00 | 1.00 | Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
FLOLAN 0.5-mg vial (7 ml/2.8 l PERFADEX) | 0.5-mg vial | Donor | 3.00 | 3.00 | Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
FLOLAN 0.5-mg vial (2.5 ml/1 l PERFADEX) | 0.5-mg vial | Donor | 1.00 | 1.00 | Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Heparin sodium 5000 units/5 ml (15,000 units/2.8 l PERFADEX) | 5-ml ampoule | Donor | 3.00 | 3.00 | BNF 201450 |
Heparin sodium 5000 units/5 ml (5000 units/1 l PERFADEX) | 5-ml ampoule | Donor | 1.00 | 1.00 | BNF 201450 |
THAM 1-ml ampoule (7 ml/2.8 l PERFADEX) | 1-ml ampoule | Donor | 7.00 | 7.00 | Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
THAM 1-ml ampoule (2.5 ml/1 l PERFADEX) | 1-ml ampoule | Donor | 3.00 | 3.00 | Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Variable costs | |||||
Travelling | |||||
Scout team | |||||
Road | Transport type/case | Donor | 0.20 | 0.20 | Brian Leadbitter, NuTH, June 2015, personal communication |
Retrieval team | |||||
Road | Transport type/case | Donor | 0.74 | 0.74 | Brian Leadbitter, NuTH, June 2015, personal communication |
Road and air | Transport type/case | Donor | 0.26 | 0.26 | Brian Leadbitter, NuTH, June 2015, personal communication |
Organ (lung) | |||||
Road | Transport type/case | Donor | 0.50 | 0.50 | Brian Leadbitter, NuTH, June 2015, personal communication |
Road and air | Transport type/case | Donor | 0.50 | 0.50 | Brian Leadbitter, NuTH, June 2015, personal communication |
Transplant preparation | |||||
Fixed costs | |||||
Contacting potential recipients | |||||
Transplant co-ordinator | Hour | Recipient | 1.00 | 1.00 | Katie Morley, NuTH, October 2014, personal communication |
Meeting potential recipients | |||||
Transplant co-ordinator | Hour | Recipient | 2.00 | 2.00 | Katie Morley, NuTH, October 2014, personal communication |
Tissue typing | |||||
Tissue typing test | Test | Recipient | 1.00 | 1.00 | Katie Morley, NuTH, October 2014, personal communication |
Tests | |||||
ABG | Test | Recipient | 1.00 | 1.00 | CRF p. 20 |
Chest X-ray (radiography) | Test | Recipient | 1.00 | 1.00 | CRF p. 21 |
ECG | Test | Recipient | 1.00 | 1.00 | Katie Morley, NuTH, October 2014, personal communication/Anne Davison, NuTH, June 2015, personal communication |
FBC | Test | Recipient | 1.00 | 1.00 | CRF p. 20 |
Ward time | |||||
Transplant centre ward | Bed-day | Recipient | 1.00 | 1.00 | Care Pathway/Katie Morley, NuTH, October 2014, personal communication |
Drugs | |||||
Azathioprine 50 mg | 56-tablet pack | Recipient | 0.02 | 0.02 | Andrew Fisher, NuTH, November 2015, personal communication |
Variable costs | |||||
Transfer to ward | |||||
Air | Transport type | Recipient | Missing | Missing | Missing |
Road | Transport type | Recipient | Missing | Missing | Missing |
EVLP procedure | |||||
Fixed costs | |||||
Staff time | |||||
Anaesthetic registrar | Hour | EVLP recipient | – | 2.00 | Katie Morley, NuTH, October 2014, personal communication/Paul Henderson, NuTH, September 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Consultant surgeon | Hour | EVLP recipient | – | 0.33 | Paul Henderson, NuTH, September 2014, personal communication |
Perfusionist (band 7) | Hour | EVLP recipient | – | 6.00 | Anna Soderlund, Vivoline, July 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Scrub nurse/ODA (band 5) | Hour | EVLP recipient | – | 3.00 | Anna Soderlund, Vivoline, July 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Surgical fellow | Hour | EVLP recipient | – | 4.00 | Anna Soderlund, Vivoline, July 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Equipment | |||||
Bronchoscope | Instrument | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
DeBakey tissue forceps | Forceps | EVLP recipient | – | 3.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
McIndoe scissors | Scissor | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Nebuliser circuit | Item | EVLP recipient | – | 1.00 | Paul Henderson, NuTH, September 2014, personal communication |
4–0 Prolene (no. 8935) suture pack | Pack | EVLP recipient | – | 2.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
10FG suction catheter (SHODS) | Catheter | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Suction connecting tubing | Tubing | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Consumables | |||||
Nylon surgical tape | Roll | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Gas (2000 l of N2/CO2) | Cylinder | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
PERFADEX solution | 1-l solution | EVLP recipient | – | 2.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Packed red blood cells | 274-ml bag | EVLP recipient | – | 2.00 | Anna Soderlund, Vivoline, July 2014, personal communication/Anders Andreasson, NuTH, September 2014, personal communication |
Syringes for blood gases | Syringe | EVLP recipient | – | 9.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Syringes (other) | Syringe | EVLP recipient | – | 10.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Vivoline disposable lung set | Set | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Miscellaneous equipment | |||||
Blood gases samples | Sample | EVLP recipient | – | 20.00 | Anna Soderlund, Vivoline, July 2014, personal communication |
Vivoline system | System | EVLP recipient | – | 1.00 | Anna Soderlund, Vivoline, July 2014, personal communication/protocol103 |
Theatre usage | |||||
Operating theatre | Hour | EVLP recipient | – | 6.00 | Protocol p. 35/Anders Andreasson, NuTH, September 2014, personal communication |
Drugs | |||||
2 l of Steen Solution | 500-ml solution | EVLP recipient | – | 4.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
Heparin sodium, 1000 units/ml | 1-ml ampoule | EVLP recipient | – | 1.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
Heparin sodium, 5000 units/ml | 1-ml ampoule | EVLP recipient | – | 2.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
Insulin human (ACTRAPID HM), 100 IU/ml | 10-ml vial | EVLP recipient | – | 1.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
Methylprednisolone (as sodium succinate) | 500-mg vial | EVLP recipient | – | 1.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
Methylprednisolone (as sodium succinate) | 1-g vial | EVLP recipient | – | 1.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
Methylprednisolone (as sodium succinate) | 2-g vial | EVLP recipient | – | 1.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
THAM, 30 mg/ml (3.0 mmol/ml) | 1-ml ampoule | EVLP recipient | – | 20.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication |
Antibiotics | |||||
Meropenem (as trihydrate) | 500-mg vial | EVLP recipient | – | 2.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication/Andrew Fisher, NuTH, November 2015, personal communication |
Moxifloxacin (as hydrochloride), 1.6 mg/ml | 250-ml solution for infusion bottle (400 mg) | EVLP recipient | – | 1.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication/Andrew Fisher, NuTH, November 2015, personal communication |
Antifungal | |||||
Amphotericin B | 50-mg vial | EVLP recipient | – | 1.00 | CRF p. 34/Anders Andreasson, NuTH, September 2014, personal communication/Andrew Fisher, NuTH, November 2015, personal communication |
Lung transplant | |||||
Fixed costs | |||||
Anaesthetic preparation | |||||
Anaesthetic room | Hour | Recipient | 0.75 | 0.75 | Transplant co-ordinators |
Anaesthetic nurse (band 5) | Hour | Recipient | 0.75 | 0.75 | Transplant co-ordinators |
Consultant anaesthetist | Hour | Recipient | 0.75 | 0.75 | Transplant co-ordinators |
Staff time | |||||
Single lung surgery | |||||
Anaesthetic fellow | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Anaesthetic nurse (band 5) | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Consultant anaesthetist | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Consultant surgeon | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Perfusionist (band 7) | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Scrub nurse (band 7) | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Scrub nurse (band 5) | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Surgical fellow | Hour | Recipient | 4.00 | 4.00 | Qualtrics survey/0Paul Henderson, NuTH, September 2014, personal communication |
Double lung surgery | |||||
Anaesthetic fellow | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Anaesthetic nurse (band 5) | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Consultant anaesthetist | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Consultant surgeon | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Perfusionist (band 7) | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Scrub nurse (band 7) | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Scrub nurse (band 5) | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Surgical fellow | Hour | Recipient | 7.00 | 7.00 | Qualtrics survey/Paul Henderson, NuTH, September 2014, personal communication |
Theatre usage | |||||
Single lung surgery | |||||
Operating theatre | Hour | Recipient | 4.00 | 4.00 | CRF p. 43/Qualtrics survey |
Double lung surgery | |||||
Operating theatre | Hour | Recipient | 7.00 | 7.00 | CRF p. 43/Qualtrics survey |
Equipment/consumables | |||||
Usual surgical set | Set | Recipient | Missing | Missing | Missing |
Post-operative care | |||||
Fixed costs | |||||
Staff time in ITU/HDU | |||||
Anaesthetic fellow | Hour | Recipient | 1.50 | 1.50 | Qualtrics survey/Andrew Fisher, NuTH, November 2015, personal communication |
Consultant anaesthetist | Hour | Recipient | 0.50 | 0.50 | Qualtrics survey/Andrew Fisher, NuTH, November 2015, personal communication |
Consultant physician | Hour | Recipient | 0.17 | 0.17 | Qualtrics survey/Andrew Fisher, NuTH, November 2015, personal communication |
Consultant surgeon | Hour | Recipient | 0.25 | 0.25 | Qualtrics survey/Andrew Fisher, NuTH, November 2015, personal communication |
Surgical fellow | Hour | Recipient | 0.25 | 0.25 | Qualtrics survey/Andrew Fisher, NuTH, November 2015, personal communication |
Staff time in hospital | |||||
Consultant physician | Hour | Recipient | 0.34 | 0.34 | Andrew Fisher, NuTH, November 2015, personal communication |
Surgical fellow | Hour | Recipient | 0.25 | 0.25 | Andrew Fisher, NuTH, November 2015, personal communication |
Transplant specialist registrar | Hour | Recipient | 0.67 | 0.67 | Andrew Fisher, NuTH, November 2015, personal communication |
Tests | |||||
ABG | Test | Recipient | 1.00 | 1.00 | CRF p. 47 |
Chest X-ray (radiography) | Test | Recipient | 1.00 | 1.00 | CRF p. 56 |
FBC | Test | Recipient | 1.00 | 1.00 | CRF p. 56 |
Pulmonary/lung function test | Test | Recipient | 1.00 | 1.00 | CRF p. 56 |
Variable costs | |||||
Ward usage (if needed) | |||||
HDU care | Bed-day | Recipient | 10.00 | 10.00 | CRF p. 51/52 |
ITU care | Bed-day | Recipient | 11.00 | 11.00 | CRF p. 51/52 |
ITU/HDU readmission | Bed-day | Recipient | 15.00 | 15.00 | CRF p. 52 |
Level 1 ward care (hospital stay) | Bed-day | Recipient | 34.00 | 34.00 | Andrew Fisher, NuTH, November 2015, personal communication/CRF p. 51/52 |
Procedures (if needed) | |||||
Bronchoscopy | Procedure | Recipient | 1.00 | 1.00 | CRF p. 46 |
Tracheostomy | Procedure | Recipient | 1.00 | 1.00 | CRF p. 51 |
Equipment (if needed) | |||||
ECMO | Machine | Recipient | 1.00 | 1.00 | CRF p. 45 |
iLA membrane ventilator | Device | Recipient | 1.00 | 1.00 | CRF p. 45 |
Consumables (if needed) | |||||
2 l of colloid (plasma and plasma substitutes) | 500 ml | Recipient | 4.00 | 4.00 | CRF p. 45 |
1 l of crystalloid (fluids containing electrolytes) | 500 ml | Recipient | 2.00 | 2.00 | CRF p. 45 |
Fresh-frozen plasma | 271-ml bag | Recipient | 3.00 | 3.00 | CRF p. 45 |
Packed red blood cells | 274-ml bag | Recipient | 4.00 | 4.00 | CRF p. 45 |
Platelets | 250-ml bag | Recipient | 2.00 | 2.00 | CRF p. 45 |
Inotropes (if needed) | |||||
Adrenaline (base), 1 mg/10 ml (1 in 10,000) | 10-ml pre-filled disposable injection | Recipient | 1.00 | 1.00 | CRF p. 45 |
Dobutamine (as hydrochloride), 12.5 mg/ml | 20-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 45 |
Glyceryl trinitrate, 1 mg/ml | 50-ml vial | Recipient | 1.00 | 1.00 | CRF p. 45 |
Milrinone, 1 mg/ml | 10-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 45 |
Noradrenaline (as acid tartrate), 1 mg/ml | 4-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 45 |
Pitressin (argipressin – synthetic vasopressin), 20 units/ml | 1-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 45 |
Other | |||||
Dopamine hydrochloride, 40 mg/ml | 5-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 46 |
Enoximone, 5 mg/ml | 20-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 46 |
Isoprenaline | – | Recipient | 1.00 | 1.00 | CRF p. 46 |
Metaraminol | – | Recipient | 1.00 | 1.00 | CRF p. 46 |
Post implantation haemodynamic support (if needed) | |||||
Adrenaline (base), 1 mg/10 ml (1 in 10,000) | 10-ml pre-filled disposable injection | Recipient | 1.00 | 1.00 | CRF p. 50 |
Dobutamine (as hydrochloride), 12.5 mg/ml | 20-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 50 |
Glyceryl trinitrate, 1 mg/ml | 50-ml vial | Recipient | 1.00 | 1.00 | CRF p. 50 |
Milrinone, 1 mg/ml | 10-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 50 |
Noradrenaline (as acid tartrate), 1 mg/ml | 4-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 50 |
Pitressin (argipressin – synthetic vasopressin), 20 units/ml | 1-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 50 |
Complications (if reported) | |||||
Cerebrovascular accident | Treatment | Recipient | 1.00 | 1.00 | CRF p. 52 |
Hemofiltration | Procedure | Recipient | 14.00 | 14.00 | CRF p. 52 |
Haemodialysis | Procedure (days) | Recipient | 9.00 | 9.00 | CRF p. 52 |
Re-exploration | Procedure | Recipient | 1.00 | 1.00 | CRF p. 52 |
Airway complications (if reported) | |||||
Balloon dilatation | Procedure | Recipient | 1.00 | 1.00 | CRF p. 53 |
Cryotherapy | Procedure | Recipient | 1.00 | 1.00 | CRF p. 53 |
Diathermy | Procedure | Recipient | 1.00 | 1.00 | CRF p. 53 |
Stenting | Procedure | Recipient | 1.00 | 1.00 | CRF p. 53 |
Surgical intervention | Procedure | Recipient | 1.00 | 1.00 | CRF p. 53 |
ITU rejection episodes (if reported) | |||||
Ward usage | |||||
HDU care | Bed-day | Recipient | 18.00 | 18.00 | CRF p. 58 |
ITU care | Bed-day | Recipient | 26.00 | 26.00 | CRF p. 58 |
Procedures | |||||
Clinical diagnosis/biopsy | Procedure | Recipient | 1.00 | 1.00 | CRF p. 57 |
Treatment | |||||
Cefuroxime (as sodium), 750 mg | 750-mg vial | Recipient | 1.00 | 1.00 | CRF p. 54 |
Methylprednisolone (as sodium succinate) | 1-g vial | Recipient | 1.00 | 1.00 | CRF p. 54 |
Piperacillin (as sodium), 2 g; and tazobactam (as sodium), 250 mg (Tazocin) | 2.25-g vial | Recipient | 1.00 | 1.00 | CRF p. 54 |
Changes in maintenance therapy | |||||
Methylprednisolone, 100 mg | 20-tablet pack | Recipient | 0.50 | 0.50 | CRF p. 54 |
Tacrolimus, 5 mg/ml | 1-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 54 |
Ward rejection episodes (if reported) | |||||
Procedures | |||||
Clinical diagnosis/biopsy | Procedure | Recipient | 1.00 | 1.00 | CRF p. 57 |
Treatment | |||||
Methylprednisolone (as sodium succinate), 500 mg | 500-mg vial | Recipient | 1.00 | 1.00 | CRF p. 57 |
Methylprednisolone (as sodium succinate) | 1-g vial | Recipient | 1.00 | 1.00 | CRF p. 57 |
Methylprednisolone, 100 mg | 20-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 57 |
Prednisolone acetate, 25 mg/ml | 1-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 57 |
Prednisolone, 25 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 57 |
Sulfamethoxazole, 400 mg; and trimethoprim, 80 mg (co-trimoxazole 480 mg) | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 57 |
Tacrolimus, 5 mg/ml | 1-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 57 |
Infection episodes (if reported) | |||||
Treatment | |||||
Aciclovir (as sodium), 25 mg/ml | 20-ml vial (500 mg) | Recipient | 15.00 | 15.00 | CRF p. 58 |
Adefovir dipivoxil, 10 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Amikacin (as sulfate), 250 mg/ml | 2-ml vial | Recipient | 30.00 | 30.00 | CRF p. 58 |
Amoxicillin (as trihydrate), 500 mg | 21-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Amoxicillin (as trihydrate), 500 mg; and clavulanic acid (as potassium), 125 mg (co-amoxiclav) | 21-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Amphotericin B liposomal (AmBisome) | 50-mg vial | Recipient | 7.00 | 7.00 | CRF p. 58 |
Amphotericin B (as sodium deoxycholate complex) | 50-mg vial | Recipient | 14.00 | 14.00 | CRF p. 58 |
Anidulafungin | 100-mg vial | Recipient | 16.00 | 16.00 | CRF p. 58 |
Azithromycin (as dihydrate), 250 mg | 4-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Aztreonam | 1-g vial | Recipient | 42.00 | 42.00 | CRF p. 58 |
BAL | Procedure | Recipient | 1.00 | 1.00 | CRF p. 58 |
Budesonide, 100 µg; and formoterol fumarate, 6 µg (Symbicort Turbohaler) | 120-dose inhaler | Recipient | 1.00 | 1.00 | CRF p. 58 |
Caspofungin (as acetate) | 70-mg vial | Recipient | 14.00 | 14.00 | CRF p. 58 |
Ceftazidime (as pentahydrate) | 2-g vial | Recipient | 42.00 | 42.00 | CRF p. 58 |
Cefuroxime (as sodium) | 750-mg vial | Recipient | 21.00 | 21.00 | CRF p. 58 |
Chloramphenicol (as sodium succinate) | 1-g vial | Recipient | 84.00 | 84.00 | CRF p. 58 |
Ciprofloxacin (as lactate), 2 mg/ml | 200-ml solution for infusion bottle | Recipient | 14.00 | 14.00 | CRF p. 58 |
Ciprofloxacin (as hydrochloride), 500 mg | 20-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Ciprofloxacin (as hydrochloride), 3 mg/ml | 5-ml 0.3% eye drops | Recipient | 2.00 | 2.00 | CRF p. 58 |
Clarithromycin | 500-mg vial | Recipient | 10.00 | 10.00 | CRF p. 58 |
Clindamycin (as phosphate), 150 mg/ml | 4-ml ampoule | Recipient | 20.00 | 20.00 | CRF p. 58 |
Colistimethate sodium | 2-million-unit vial | Recipient | 28.00 | 28.00 | CRF p. 58 |
Domperidone (as maleate), 10 mg | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Doxycycline (as hyclate), 100 mg | 8-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Eradication therapy for H. pylori | 7-day course | Recipient | 1.00 | 1.00 | CRF p. 58 |
Ertapenem (as sodium) | 1-g vial | Recipient | 14.00 | 14.00 | CRF p. 58 |
Ethambutol hydrochloride, 100 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Flucloxacillin (as sodium) | 28-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Flucloxacillin (as sodium) | 1-g vial | Recipient | 12.00 | 12.00 | CRF p. 58 |
Fluconazole, 50 mg | 7-capsule pack | Recipient | 8.00 | 8.00 | CRF p. 58 |
Fluconazole, 2 mg/ml | 100-ml solution for infusion bottle | Recipient | 43.00 | 43.00 | CRF p. 58 |
Fluconazole, 50 mg | 7-capsule pack | Recipient | 8.00 | 8.00 | CRF p. 58 |
Foscarnet sodium, 24 mg/ml | 250-ml solution for infusion bottle | Recipient | 42.00 | 42.00 | CRF p. 58 |
Fosfomycin (as sodium) | 2-g vial | Recipient | 30.00 | 30.00 | CRF p. 58 |
Furosemide, 10 mg/ml | 5-ml ampoule | Recipient | 21.00 | 21.00 | CRF p. 58 |
Ganciclovir (as sodium) | 500-mg vial | Recipient | 42.00 | 42.00 | CRF p. 58 |
Gentamycin (as sulfate), 40 mg/ml | 2-ml vial | Recipient | 28.00 | 28.00 | CRF p. 58 |
Immunoglobulin | 10-g vial | Recipient | 1.00 | 1.00 | CRF p. 58 |
Itraconazole, 10 mg/ml | 25-ml ampoule | Recipient | 16.00 | 16.00 | CRF p. 58 |
Lamivudine, 150 mg | 60-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Lesion excision | Day case | Recipient | 1.00 | 1.00 | CRF p. 58 |
Linezolid, 2 mg/ml | 300-ml infusion bag | Recipient | 84.00 | 84.00 | CRF p. 58 |
Meropenem (as trihydrate) | 1-g vial | Recipient | 12.25 | 12.25 | CRF p. 58 |
Methylprednisolone (as sodium succinate) | 1-g vial | Recipient | 3.00 | 3.00 | CRF p. 58 |
Metochlopramide hydrochloride, 5 mg/ml | 2-ml ampoule | Recipient | 15.00 | 15.00 | CRF p. 58 |
Metronidazole, 200 mg | 21-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 58 |
Micafungin (as sodium) | 100-mg vial | Recipient | 14.00 | 14.00 | CRF p. 58 |
Moxifloxacin (as hydrochloride), 1.6 mg/ml | 250-ml solution for infusion bottle | Recipient | 14.00 | 14.00 | CRF p. 58 |
Oseltamivir (as phosphate), 75 mg | 10-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Packed red blood cells | 274-ml bag | Recipient | 1.00 | 1.00 | CRF p. 58 |
Piperacillin (as sodium), 4 g; and tazobactam (as sodium), 500 mg (Tazocin) | 4.5-g vial | Recipient | 43.00 | 43.00 | CRF p. 58 |
Posaconazole, 100 mg | 96-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Prednisolone, 25 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Respiratory failure (inpatient) | Treatment | Recipient | 1.00 | 1.00 | CRF p. 58 |
Sirolimus, 2 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Streptokinase | 250,000-unit powder vial | Recipient | 12.00 | 12.00 | CRF p. 58 |
Sulfamethoxazole, 80 mg; and trimethoprim, 16 mg (Septrin) | 5-ml ampoule | Recipient | 24.00 | 24.00 | CRF p. 58 |
Surgical intervention or VATS | Procedure | Recipient | 1.00 | 1.00 | CRF p. 58 |
Teicoplanin | 200-mg vial | Recipient | 10.00 | 10.00 | CRF p. 58 |
Trimethoprim, 100 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Tobramycin (as sulfate), 40 mg/ml | 1-ml vial | Recipient | 12.25 | 12.25 | CRF p. 58 |
Tigecycline | 50-mg vial | Recipient | 30.00 | 30.00 | CRF p. 58 |
Valganciclovir (as hydrochloride), 450 mg | 60-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 58 |
Vancomycin (as hydrochloride) | 1-g vial | Recipient | 14.00 | 14.00 | CRF p. 58 |
Voriconazole | 200-mg vial | Recipient | 34.00 | 34.00 | CRF p. 58 |
Ward usage | |||||
HDU care | Bed-day | Recipient | 18.00 | 18.00 | CRF p. 58 |
ITU care | Bed-day | Recipient | 26.00 | 26.00 | CRF p. 58 |
Outpatient care | |||||
Fixed costs | |||||
Outpatient reviews | |||||
Bronchoscopy | Procedure/visit (4 visits) | Recipient | 1.00 | 1.00 | CRF |
Chest X-ray (radiography) | Test/visit (4 visits) | Recipient | 1.00 | 1.00 | CRF |
FBC | Test/visit (4 visits) | Recipient | 1.00 | 1.00 | CRF |
Liver function test | Test/visit (4 visits) | Recipient | 1.00 | 1.00 | Andrew Fisher, NuTH, November 2015, personal communication |
Pulmonary/lung function test | Test/visit (4 visits) | Recipient | 1.00 | 1.00 | CRF |
Urea and electrolytes test | Test/visit (4 visits) | Recipient | 1.00 | 1.00 | Andrew Fisher, NuTH, November 2015, personal communication |
Staff time | |||||
Consultant physician | Hour/visit (4 visits) | Recipient | 0.50 | 0.50 | Care pathway/Katie Morley, NuTH, October 2014, personal communication |
Scrub nurse (band 5) | Hour/visit (4 visits) | Recipient | 0.50 | 0.50 | Care pathway/Katie Morley, NuTH, October 2014, personal communication |
Variable costs | |||||
Rejection episodes (if reported) | |||||
Procedures | |||||
Clinical diagnosis/biopsy | Procedure | Recipient | 1.00 | 1.00 | CRF |
Ventilation–perfusion scan | Test | Recipient | 1.00 | 1.00 | CRF |
Treatment | |||||
Anti-thymocyte immunoglobulin (rabbit), 25 mg | 25-mg vial | Recipient | 40.00 | 40.00 | CRF |
Azathioprine, 25 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Azathioprine, 50 mg | 56-tablet pack | Recipient | 2.00 | 2.00 | CRF |
Ciclosporin, 25 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin, 50 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin, 100 mg | 30-capsule pack | Recipient | 3.00 | 3.00 | CRF |
Ciclosporin (NEORAL), 10 mg | 60-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin (NEORAL), 25 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin (NEORAL), 50 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin (NEORAL), 100 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Immunoglobulin | 10-g vial | Recipient | 1.00 | 1.00 | CRF |
Meropenem (as trihydrate) | 1-g vial | Recipient | 30.00 | 30.00 | CRF |
Methylprednisolone (as sodium succinate) | 125-mg vial | Recipient | 4.00 | 4.00 | CRF |
Methylprednisolone (as sodium succinate) | 500-mg vial | Recipient | 3.00 | 3.00 | CRF |
Methylprednisolone (as sodium succinate) | 1-g vial | Recipient | 3.00 | 3.00 | CRF |
Mycophenolate mofetil, 500 mg | 50-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Mycophenolate mofetil, 250 mg | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Prednisolone, 1 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Prednisolone, 5 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF |
Prednisolone, 25 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Rituximab, 100 mg/ml | 10-ml vial | Recipient | 4.00 | 4.00 | CRF |
Tacrolimus (Prograf), 500 µg | 50-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus (Prograf), 1 mg | 50-capsule pack | Recipient | 4.00 | 4.00 | CRF |
Tacrolimus (Prograf), 1 mg | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus (Prograf), 5 mg | 50-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Valganciclovir (as hydrochloride), 450 mg | 60-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Ward usage | |||||
HDU care | Bed-day | Recipient | 30.00 | 30.00 | CRF |
ITU care | Bed-day | Recipient | 7.00 | 7.00 | CRF |
GP visits (if needed) | |||||
Out-of-surgery visit | Visit | Recipient | 1.00 | 1.00 | CRF |
Surgery visit | Visit | Recipient | 1.00 | 1.00 | CRF |
Transplant centre advice | Call | Recipient | 1.00 | 1.00 | CRF |
Unplanned hospital admission (if needed) | |||||
Treatment | |||||
Aciclovir (as sodium), 25 mg/ml | 20-ml vial | Recipient | 15.00 | 15.00 | CRF |
Aciclovir, 400 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Adrenaline (base), 100 µg/ml (1 in 10,000) | 10-ml pre-filled disposable injection | Recipient | 1.00 | 1.00 | CRF |
Amiodarone hydrochloride, 30 mg/ml | 10-ml pre-filled disposable injection | Recipient | 7.00 | 7.00 | CRF |
Amoxicillin (as sodium), 500 mg; and clavulanic acid (as potassium), 125 mg (co-amoxiclav) | 500/100-mg vial | Recipient | 15.00 | 15.00 | CRF |
Amphotericin B | 50-mg vial | Recipient | 14.00 | 14.00 | CRF |
Aspirin, 300 mg | 32-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Azathioprine, 25 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Azithromycin (as dihydrate), 250 mg | 4-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Aztreonam | 1-g vial | Recipient | 42.00 | 42.00 | CRF |
Balloon dilatation | Procedure | Recipient | 1.00 | 1.00 | CRF |
Basiliximab | 20-mg vial | Recipient | 2.00 | 2.00 | CRF |
Bisoprolol fumarate, 10 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Bortezomib | 3.5-mg vial | Recipient | 1.00 | 1.00 | CRF |
Bronchoscopy | Procedure | Recipient | 1.00 | 1.00 | CRF |
Budesonide, 100 µg; and formoterol fumarate dihydrate, 6 µg (Symbicort 100/6 Turbohaler®) | 120-dose unit inhaler | Recipient | 1.00 | 1.00 | CRF |
Calcium gluconate, 1 g | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Calcium polystyrene sulfonate (Calcium Resonium) | 300-g powder | Recipient | 1.00 | 1.00 | CRF |
Candesartan cilexetil, 4 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF |
Caspofungin (as acetate) | 70-mg vial | Recipient | 14.00 | 14.00 | CRF |
Ciclosporin, 100 mg | 30-capsule pack | Recipient | 2.00 | 2.00 | CRF |
Ciclosporin, 50 mg/ml | 5-ml ampoule | Recipient | 17.00 | 17.00 | CRF |
Ciprofloxacin (as hydrochloride), 500 mg | 20-tablet pack | Recipient | 2.00 | 2.00 | CRF |
Clarithromycin | 500-mg vial | Recipient | 10.00 | 10.00 | CRF |
Clinical diagnosis/biopsy | Procedure | Recipient | 1.00 | 1.00 | CRF |
Colistimethate sodium | 1-million-unit vial | Recipient | 28.00 | 28.00 | CRF |
Colistimethate sodium | 2-million-unit vial | Recipient | 28.00 | 28.00 | CRF |
Computerised tomography | Procedure | Recipient | 1.00 | 1.00 | CRF |
DeBakey tissue forceps | Forceps | Recipient | 1.00 | 1.00 | CRF |
Docusate sodium, 100 mg | 30-capsule pack | Recipient | 4.00 | 4.00 | CRF |
Doxazosin (as mesilate), 4 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF |
Doxycycline (as hyclate), 100 mg | 8-capsule pack | Recipient | 1.00 | 1.00 | CRF |
ECG | 24-hour test | Recipient | 24.00 | 24.00 | CRF |
Enoxaparin sodium (Clexane Forte), 150 mg | 1-ml pre-filled disposable injection | Recipient | 5.00 | 5.00 | CRF |
ECMO | Machine | Recipient | 1.00 | 1.00 | CRF |
Filgrastim, 30 million units (300 µg/ml) | 1-ml vial | Recipient | 14.00 | 14.00 | CRF |
Flucloxacillin (as sodium) | 1-g vial | Recipient | 12.00 | 12.00 | CRF |
Fluticasone propionate, 250 µg; and salmeterol xinafoate, 50 µg (Seretide 250 Accuhaler) | 120-unit dose inhaler | Recipient | 1.00 | 1.00 | CRF |
Foscarnet sodium, 24 mg/ml | 250-ml solution for infusion bottle | Recipient | 1.00 | 1.00 | CRF |
Furosemide, 10 mg/ml | 5-ml ampoule | Recipient | 21.00 | 21.00 | CRF |
Ganciclovir (as sodium) | 500-mg vial | Recipient | 42.00 | 42.00 | CRF |
Gastrograffin | Solution | Recipient | 1.00 | 1.00 | CRF |
Glucose anhydrous, 50 mg/ml | 1000-ml bag | Recipient | 7.00 | 7.00 | CRF |
iLA membrane ventilator | Device | Recipient | 1.00 | 1.00 | CRF |
Immunoglobulin | 10-g vial | Recipient | 1.00 | 1.00 | CRF |
Insulin, 3 ml | 5 × 3-ml pre-filled disposable injection devices | Recipient | 1.00 | 1.00 | CRF |
Intubation | Procedure | Recipient | 1.00 | 1.00 | CRF |
Hydralazine hydrochloride, 50 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Hydrocortisone (as sodium succinate) | 100-mg vial | Recipient | 28.00 | 28.00 | CRF |
Lansoprazole, 30 mg | 28-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Level 1 ward care (hospital stay) | Bed-day | Recipient | 1.00 | 1.00 | CRF |
Macrogol compound oral powder | 50-sachet pack | Recipient | 1.00 | 1.00 | CRF |
Magnesium hydroxide with liquid paraffin | 150-ml bottle | Recipient | 1.00 | 1.00 | CRF |
Magnesium sulfate heptahydrate, 100 mg | 10-ml ampoule | Recipient | 1.00 | 1.00 | CRF |
Magnetic resonance imaging scan | Test | Recipient | 1.00 | 1.00 | CRF |
Meropenem (as trihydrate) | 1-g vial | Recipient | 11.00 | 11.00 | CRF |
Methylprednisolone (as sodium succinate), 500 mg | 500-mg vial | Recipient | 3.00 | 3.00 | CRF |
Methylprednisolone (as sodium succinate) | 1-g vial | Recipient | 3.00 | 3.00 | CRF |
Metoclopramide hydrochloride, 5 mg/ml | 2-ml ampoule | Recipient | 4.00 | 4.00 | CRF |
Midazolam (as hydrochloride), 1 mg/ml | 5-ml ampoule | Recipient | 1.00 | 1.00 | CRF |
Minocycline (as hydrochloride), 100 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Moxifloxacin (as hydrochloride), 1.6 mg/ml | 250-ml solution for infusion bottle | Recipient | 14.00 | 14.00 | CRF |
Nefopam hydrochloride, 30 mg | 90-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Non-invasive ventilation | Procedure | Recipient | 1.00 | 1.00 | CRF |
Normal immunoglobulin, 10 g | 200-ml solution for infusion bottle | Recipient | 1.00 | 1.00 | CRF |
Oxycodone hydrochloride, 10 mg/ml | 120-ml oral solution | Recipient | 1.00 | 1.00 | CRF |
Packed red blood cells | 274-ml bag | Recipient | 2.00 | 2.00 | CRF |
Phosphate enema | 133-ml enema pack | Recipient | 1.00 | 1.00 | CRF |
Piperacillin (as sodium), 4 g; and tazobactam (as sodium), 500 mg (Tazocin) | 4.5-g vial | Recipient | 40.00 | 40.00 | CRF |
Posaconazole, 100 mg | 96-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Prednisolone, 5 mg | 28-tablet pack | Recipient | 4.00 | 4.00 | CRF |
Pregabalin, 150 mg | 56-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Redo lung transplantation | Procedure | Recipient | 1.00 | 1.00 | CRF |
Renal support | Treatment | Recipient | 1.00 | 1.00 | CRF |
Ribavirin, 200 mg | 42-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Ribavirin, 400 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Salbutamol (as sulfate), 5 mg/2.5 ml | 20-unit dose nebuliser liquid vial | Recipient | 1.00 | 1.00 | CRF |
Sirolimus, 2 mg | 30-tablet pack | Recipient | 2.00 | 2.00 | CRF |
Sodium bicarbonate, 42 mg/ml | 500-ml intravenous infusion bottle | Recipient | 1.00 | 1.00 | CRF |
2 l of 0.9% sodium chloride solution | 1-l solution | Recipient | 20.00 | 20.00 | CRF |
Stenting | Procedure | Recipient | 1.00 | 1.00 | CRF |
Sulfamethoxazole, 80 mg; and trimethoprim, 16 mg (Septrin) | 5-ml ampoule | Recipient | 18.00 | 18.00 | CRF |
Sulfamethoxazole, 400 mg; and trimethoprim, 80 mg (co-trimoxazole) | 5-ml ampoule | Recipient | 12.00 | 12.00 | CRF |
Surgical intervention | Procedure | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus (Prograf), 1 mg | 50-capsule pack | Recipient | 4.00 | 4.00 | CRF |
Tacrolimus (Prograf), 1 mg | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus (Prograf), 5 mg/ml | 10 × 1-ml ampoules | Recipient | 7.00 | 7.00 | CRF |
Tinzaparin sodium, 20,000 units/ml (Innohep) | 0.5-ml vial | Recipient | 630.00 | 630.00 | CRF |
Tracheostomy | Procedure | Recipient | 1.00 | 1.00 | CRF |
Tramadol hydrochloride, 150 mg | 60-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ultrasound scan | Test | Recipient | 1.00 | 1.00 | CRF |
Valganciclovir (as hydrochloride), 450 mg | 60-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Vancomycin (as hydrochloride), 125 mg | 28-capsule pack | Recipient | 2.00 | 2.00 | CRF |
Voriconazole | 200-mg vial | Recipient | 78.00 | 78.00 | CRF |
Warfarin sodium, 3 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Warfarin sodium, 1 mg/ml | 150-ml oral suspension | Recipient | 3.00 | 3.00 | CRF |
Ward usage | |||||
HDU care | Bed-day | Recipient | 14.00 | 14.00 | CRF |
ITU care | Bed-day | Recipient | 14.00 | 14.00 | CRF |
Immunosuppressive medications (if needed) | |||||
Azathioprine, 25 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Azathioprine, 50 mg | 56-tablet pack | Recipient | 3.00 | 3.00 | CRF/Ruth Coxhead, NuTH, March 2015, personal communication |
Ciclosporin, 25 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin, 50 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin, 100 mg | 30-capsule pack | Recipient | 4.00 | 4.00 | CRF/Ruth Coxhead, NuTH, March 2015, personal communication |
Mycophenolate mofetil, 500 mg | 50-tablet pack | Recipient | 3.00 | 3.00 | CRF/Ruth Coxhead, NuTH, March 2015, personal communication |
Prednisolone, 1 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Prednisolone, 5 mg | 28-tablet pack | Recipient | 3.00 | 3.00 | CRF/Ruth Coxhead, NuTH, March 2015, personal communication |
Prednisolone, 25 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Prednisolone acetate, 25 mg/ml | 1-ml ampoule | Recipient | 26.00 | 26.00 | CRF |
Sirolimus, 500 µg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Sirolimus, 1 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Sirolimus, 2 mg | 30-tablet pack | Recipient | 2.00 | 2.00 | CRF/Ruth Coxhead, NuTH, March 2015, personal communication |
Tacrolimus, 500 µg | 50-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus, 1 mg | 50-capsule pack | Recipient | 4.00 | 4.00 | CRF/Ruth Coxhead, NuTH, March 2015, personal communication |
Tacrolimus, 1 mg | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus, 5 mg | 50-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Other | |||||
Aciclovir, 200 mg | 25-tablet pack | Recipient | 28.00 | 28.00 | CRF |
Amoxicillin (as trihydrate), 500 mg | 21-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Azithromycin (as dihydrate), 250 mg | 4-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Beclomethasone dipropionate, 400 µg/dose | 100-dose unit | Recipient | 1.00 | 1.00 | CRF |
Calcium carbonate (Adcal), 1.5 g | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Cetirizine hydrochloride, 10 mg | 30-tablet pack | Recipient | 3.00 | 3.00 | CRF |
Ciclosporin (NEORAL), 10 mg | 60-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin (NEORAL), 25 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Ciclosporin (NEORAL), 50 mg | 50-capsule pack | Recipient | 2.00 | 2.00 | CRF |
Ciclosporin, 100 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Citalopram (as hydrobromide), 20 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Dapsone, 100 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Dexamethasone, 2 mg | 50-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Doxycycline (as hyclate), 100 mg | 8-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Furosemide, 40 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Hydrocortisone, 10 mg | 30-tablet pack | Recipient | 5.00 | 5.00 | CRF |
Hydrocortisone, 20 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Lisinopril dihydrate, 2.5 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Lisinopril dihydrate, 5 mg | 28-tablet pack | Recipient | 4.00 | 4.00 | CRF |
Methylprednisolone, 2 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Methylprednisolone (as sodium succinate) | 40-mg vial | Recipient | 1.00 | 1.00 | CRF |
Methylprednisolone (as sodium succinate) | 1-g vial | Recipient | 1.00 | 1.00 | CRF |
Mycophenolic acid (as sodium), 180 mg | 120-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Mycophenolic acid (as sodium), 360 mg | 120-tablet pack | Recipient | 1.00 | 1.00 | CRF |
N-acetylcysteine, 200 mg/ml | 10-ml ampoule | Recipient | 1.00 | 1.00 | CRF |
Perindopril erbumine, 2 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Perindopril erbumine, 4 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Sulfamethoxazole, 400 mg; and trimethoprim, 80 mg (co-trimoxazole) | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus (Prograf), 1 mg | 50-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Tacrolimus (Prograf), 1 mg | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF |
Tinzaparin sodium, 3500 units | 0.35-ml pre-filled disposable injection | Recipient | 1.00 | 1.00 | CRF |
Concomitant medications | |||||
Variable costs | |||||
Treatment | |||||
Aciclovir, 200 mg | 25-tablet pack | Recipient | 9.00 | 9.00 | CRF p. 111 |
Adrenaline (base), 100 µg/ml (1 in 10,000) | 10-ml pre-filled disposable injection | Recipient | 15.00 | 15.00 | CRF p. 111 |
Alendronic acid (as sodium), 70 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Alfentanil (as hydrochloride), 500 µg/ml | 2-ml ampoule | Recipient | 2.00 | 2.00 | CRF p. 111 |
Alfentanil (as hydrochloride), 5 mg/ml | 1-ml ampoule | Recipient | 9.00 | 9.00 | CRF p. 111 |
Allopurinol, 300 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Amiloride hydrochloride, 5 mg; and furosemide, 40 mg (co-amilofruse) | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Amiodarone hydrochloride, 30 mg/ml | 10-ml pre-filled disposable syringe | Recipient | 60.00 | 60.00 | CRF p. 111 |
Amiodarone hydrochloride, 100 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Amiodarone hydrochloride, 200 mg | 28-tablet pack | Recipient | 6.00 | 6.00 | CRF p. 111 |
Amitriptyline hydrochloride, 10 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Amlodipine, 5 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Amlodipine, 10 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Amoxicillin (as trihydrate), 500 mg | 21-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Amoxicillin (as amoxicillin trihydrate), 500 mg; and clavulanic acid (as potassium), 125 mg | 21-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Amphotericin B, 5 mg/ml | 20-lozenge pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Amphotericin B (as phospholipid complex, 5 mg/ml | 20-ml vial | Recipient | 2.00 | 2.00 | CRF p. 111 |
Antiembolism socks | Socks pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Anti-thymocyte immunoglobulin (rabbit) | 25-mg vial | Recipient | 20.00 | 20.00 | CRF p. 111 |
Aspirin, 75 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Atracurium besilate, 10 mg/ml | 5-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 111 |
Azathioprine, 25 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Azathioprine, 50 mg | 56-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Azithromycin (as dihydrate), 250 mg | 4-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Azithromycin (as dihydrate), 250 mg | 6-capsule pack | Recipient | 9.00 | 9.00 | CRF p. 111 |
Azithromycin, 500 mg | 3-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Aztreonam | 2-g vial | Recipient | 12.00 | 12.00 | CRF p. 111 |
Bisoprolol fumarate, 1.25 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Bisoprolol fumarate, 2.5 mg | 28-tablet pack | Recipient | 5.00 | 5.00 | CRF p. 111 |
Bisoprolol fumarate, 5 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Bupivacaine hydrochloride, 1 mg/ml | 100-ml infusion bag | Recipient | 1.00 | 1.00 | CRF p. 111 |
Calcium carbonate (Adcal), 1.5 g | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Calcium carbonate, 1.25 g; and colecalciferol, 400 units (Calcichew D3 Forte) | 60-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Calcium chloride dihydrate, 10% | 10-ml pre-filed disposable injection | Recipient | 1.00 | 1.00 | CRF p. 111 |
Calogen emulsion | 500-ml bottle | Recipient | 4.00 | 4.00 | CRF p. 111 |
Carbocisteine, 375 mg | 120-capsule pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Caspofungin (as acetate) | 50-mg vial | Recipient | 18.00 | 18.00 | CRF p. 111 |
Ceftazidime (as pentahydrate) | 2-g vial | Recipient | 11.00 | 11.00 | CRF p. 111 |
Chlordiazepoxide hydrochloride, 5 mg | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Chlordiazepoxide hydrochloride (Librium), 10 mg | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Chlorhexidine gluconate, 4% | 500-ml surgical scrub | Recipient | 1.00 | 1.00 | CRF p. 111 |
Chlorhexidine hydrochloride, 500 mg | 500-mg pump pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Chlorhexidine hydrochloride, 1 mg/g; and neomycin sulfate, 5 mg/g (Naseptin) | 15-g nasal cream | Recipient | 8.00 | 8.00 | CRF p. 111 |
Chlorhexidine hydrochloride, 10 mg/g; and nystatin, 100,000 units/g (Nystaform) | 30-g cream | Recipient | 1.00 | 1.00 | CRF p. 111 |
Chlorphenamine maleate, 10 mg/ml | 1-ml ampoule | Recipient | 3.00 | 3.00 | CRF p. 111 |
Chlorpromazine hydrochloride, 25 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ciclosporin (NEORAL), 25 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ciclosporin, 50 mg | 30-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ciclosporin, 100 mg | 30-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ciprofloxacin (as hydrochloride), 500 mg (Ciproxin) | 10-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Ciprofloxacin (as hydrochloride), 750 mg | 10-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Citalopram (as hydrobromide), 20 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Citalopram (as hydrobromide), 40 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Clonidine hydrochloride, 25 µg | 112-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Codeine phosphate, 8 mg; and paracetamol, 500 mg | 30-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Codeine phosphate 30 mg and paracetamol, 500 mg | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Codeine phosphate, 30 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Codeine phosphate, 60 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Colecalciferol, 500 µg (20,000 units) | 15-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Colistimethate sodium | 1-million-unit vial | Recipient | 56.00 | 56.00 | CRF p. 111 |
Colistimethate sodium | 2-million-unit vial | Recipient | 28.00 | 28.00 | CRF p. 111 |
CREON, 25,000 units | 100-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
CREON Micro Pancreatine, 20 g | 60.12-mg granules | Recipient | 1.00 | 1.00 | CRF p. 111 |
Cryoprecipitate | 8 units | Recipient | 1.00 | 1.00 | CRF p. 111 |
Cyclizine hydrochloride, 50 mg | 100-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Dapsone, 100 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Diazepam, 2 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Digoxin, 250 µg/ml | 2-ml ampoule | Recipient | 28.00 | 28.00 | CRF p. 111 |
Diltiazem hydrochloride, 120 mg | 28-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Diltiazem hydrochloride, 200 mg | 7-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Docusate sodium | 100-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Domperidone (as maleate), 10 mg | 100-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Dopamine hydrochloride, 40 mg/ml | 5-ml ampoule | Recipient | 8.00 | 8.00 | CRF p. 111 |
Dosulepin hydrochloride, 25 mg | 28-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Doxazosin (as mesilate), 4 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Doxycycline (as hyclate), 100 mg | 8-capsule pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Enoxaparin sodium, 100 mg/ml | 0.4-ml pre-filled disposable injection | Recipient | 19.00 | 19.00 | CRF p. 111 |
Ensure liquid | 250 ml | Recipient | 1.00 | 1.00 | CRF p. 111 |
Erythromycin (as lactobionate) | 1-g vial | Recipient | 18.00 | 18.00 | CRF p. 111 |
Esomeprazole (as magnesium dihydrate), 40 mg | 28-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ethambutol hydrochloride, 400 mg | 56-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ezetimibe, 10 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ethinylestradiol, 30 µg; and gestodene, 75 µg | 21-day preparation | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ferrous sulfate dried, 200 mg | 28-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Flucloxacillin (as sodium), 500 mg | 28-capsule pack | Recipient | 8.00 | 8.00 | CRF p. 111 |
Flucloxacillin (as sodium) | 1-g vial | Recipient | 5.00 | 5.00 | CRF p. 111 |
Fluconazole, 50 mg | 7-capsule pack | Recipient | 7.00 | 7.00 | CRF p. 111 |
Fluconazole, 200 mg | 7-capsule pack | Recipient | 11.00 | 11.00 | CRF p. 111 |
Fluconazole, 2 mg/ml | 100-ml solution for infusion bottle | Recipient | 12.00 | 12.00 | CRF p. 111 |
Fluoxetine (as hydrochloride), 20 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Fluticasone propionate 50 µg | 150-unit dose nasal spray | Recipient | 1.00 | 1.00 | CRF p. 111 |
Fluticasone propionate, 250 µg (Flixotide 250 Accuhaler) | 60-dose inhaler | Recipient | 1.00 | 1.00 | CRF p. 111 |
Fluticasone propionate, 250 µg; and salmeterol xinafoate, 50 µg (Seretide 250 Accuhaler) | 60-dose inhaler | Recipient | 1.00 | 1.00 | CRF p. 111 |
Folic acid, 400 µg | 90-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Foscarnet sodium, 24 mg/ml | 250-ml solution for infusion bottle | Recipient | 42.00 | 42.00 | CRF p. 111 |
Fosfomycin (as sodium) | 2-g vial | Recipient | 2.00 | 2.00 | CRF p. 111 |
Fresh-frozen plasma | 271-ml bag | Recipient | 7.00 | 7.00 | CRF p. 111 |
Furosemide, 10 mg/ml | 2-ml ampoule | Recipient | 14.00 | 14.00 | CRF p. 111 |
Furosemide, 20 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Furosemide, 40 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ganciclovir (as sodium) | 500-mg vial | Recipient | 21.00 | 21.00 | CRF p. 111 |
Gelatin (Gelofusine) | 1-l infusion bag | Recipient | 2.00 | 2.00 | CRF p. 111 |
Gelatin, 140 mg/g; and glycerol, 700 mg/g | 4-g supplement pack | Recipient | 72.00 | 72.00 | CRF p. 111 |
Gliclazide (glycoside), 30 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Gliclazide, 40 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Glucose anhydrous, 500 mg/ml | 50-ml vial | Recipient | 168.00 | 168.00 | CRF p. 111 |
Glyceryl trinitrate, 1 mg/ml | 50-ml ampoule | Recipient | 10.00 | 10.00 | CRF p. 111 |
Haloperidol, 5 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Haloperidol, 5 mg/ml | 1-ml ampoule | Recipient | 248.00 | 248.00 | CRF p. 111 |
Heparin sodium, 5000 units/ml | 1-ml ampoule | Recipient | 49.00 | 49.00 | CRF p. 111 |
Heparin sodium, 5000 units/ml | 5-ml ampoule | Recipient | 6.00 | 6.00 | CRF p. 111 |
Hydroxocobalamin, 1 mg/ml | 1-ml ampoule | Recipient | 14.00 | 14.00 | CRF p. 111 |
Hyoscine butylbromide (Buscopan), 10 mg | 56-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Ibandronic acid (as sodium monohydrate), 50 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Iloprost (as THAM), 10 µg/ml | 30 × 1-ml unit-dose vials | Recipient | 1.00 | 1.00 | CRF p. 111 |
Insulin, 3 ml | 5 × 3-ml pre-filled disposable injection devices | Recipient | 1.00 | 1.00 | CRF p. 111 |
Insulin aspart, 100 units/ml | 5 × 3-ml pre-filled disposable injection devices | Recipient | 2.00 | 2.00 | CRF p. 111 |
Insulin human (as soluble human) (ACTRAPID), 100 units/ml | 10-ml vial | Recipient | 27.00 | 27.00 | CRF p. 111 |
Insulin human (as detemir), 100 units/ml (LEMEVIR) | 5 × 3-ml pre-filled disposable injection device | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ipratropium bromide, 250 µg/ml | 60 × 1 ml unit-dose vial | Recipient | 4.00 | 4.00 | CRF p. 111 |
Ipratropium bromide, 500 µg | 500-µg nebuliser solution | Recipient | 4.00 | 4.00 | CRF p. 111 |
Ipratropium bromide, 2.5 mg/2.5 ml | 60-unit-dose vial | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ipratropium bromide, 200 µg/ml; and salbutamol (as sulfate), 1 mg/ml (Combivent) | 60-unit dose vial | Recipient | 9.00 | 9.00 | CRF p. 111 |
Itraconazole, 100 mg | 15-capsule pack | Recipient | 10.00 | 10.00 | CRF p. 111 |
Itraconazole, 10 mg/ml | 150-ml oral solution | Recipient | 33.00 | 33.00 | CRF p. 111 |
Labetalol hydrochloride, 100 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Labetalol hydrochloride, 200 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Lactulose | 300-ml solution | Recipient | 1.00 | 1.00 | CRF p. 111 |
Lansoprazole, 15 mg | 28-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Lansoprazole, 30 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Loratadine, 10 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Levomepromazine maleate, 25 mg | 84-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Linezolid, 600 mg | 10-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Loperamide hydrochloride, 2 mg | 30-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Lorazepam, 1 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Lymecycline, 408 mg | 28-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Magnesium oxide, 160 mg | 28-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Magnesium sulfate heptahydrate, 500 mg/ml | 2-ml ampoule | Recipient | 98.00 | 98.00 | CRF p. 111 |
Magnesium sulfate heptahydrate, 500 mg/ml | 5-ml ampoule | Recipient | 29.00 | 29.00 | CRF p. 111 |
Magnesium sulfate heptahydrate, 500 mg/ml | 4-ml ampoule | Recipient | 56.00 | 56.00 | CRF p. 111 |
Menadiol phosphate (as sodium phosphate), 10 mg | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Meropenem (as trihydrate) | 1-g vial | Recipient | 24.50 | 24.50 | CRF p. 111 |
MEROCAINE | 24-lozenge pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Methylprednisolone (as sodium succinate) | 500-mg vial | Recipient | 26.00 | 26.00 | CRF p. 111 |
Methylprednisolone (as sodium succinate) | 1-g vial | Recipient | 3.00 | 3.00 | CRF p. 111 |
Metformin hydrochloride, 500 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Metoclopramide hydrochloride, 10 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Metronidazole, 400 mg | 21-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Midazolam (as hydrochloride), 1 mg/ml | 5-ml ampoule | Recipient | 2.00 | 2.00 | CRF p. 111 |
Milrinone (as lactate), 1 mg/ml | 10-ml ampoule | Recipient | 228.00 | 228.00 | CRF p. 111 |
Minocycline (as hydrochloride), 100 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Mirtazapine, 30 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | BNF 201450 |
Montelukast (as sodium), 10 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Mometasone furoate, 50 µg | 140-unit dose nasal spray | Recipient | 1.00 | 1.00 | CRF p. 111 |
Morphine sulfate, 1 mg/ml | 10-mg disposable syringe | Recipient | 16.00 | 16.00 | CRF p. 111 |
Morphine sulfate (Oramorph), 10 mg/5ml | 300-ml oral solution | Recipient | 1.00 | 1.00 | CRF p. 111 |
Movicol | 30-sachet pack | Recipient | 6.00 | 6.00 | CRF p. 111 |
Moxifloxacin (as hydrochloride), 400 mg | 5-tablet pack | Recipient | 18.00 | 18.00 | CRF p. 111 |
Multivitamins | 28-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Mupirocin, 20 mg/g | 15-g ointment | Recipient | 1.00 | 1.00 | CRF p. 111 |
Micafungin (as sodium) | 100-mg vial | Recipient | 14.00 | 14.00 | CRF p. 111 |
N-acetylcysteine, 600 mg | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Naproxen, 500 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Nebivolol (as hydrochloride), 5 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Nifedipine, 5 mg | 84-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Nifedipine, 10 mg | 84-capsule pack | Recipient | 5.00 | 5.00 | CRF p. 111 |
Noradrenaline base, 1 mg/ml (as noradrenaline acid tartrate, 2 mg/ml) | 4-ml ampoule | Recipient | 32.00 | 32.00 | CRF p. 111 |
Nutrison energy multifibre | 1000-ml solution | Recipient | 28.00 | 28.00 | CRF p. 111 |
Nystatin, 100,000 units/ml | 30-ml oral suspension | Recipient | 4.00 | 4.00 | CRF p. 111 |
Omeprazole (as magnesium), 10 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Omeprazole (as magnesium), 20 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Omeprazole (as magnesium), 40 mg | 28-capsule pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Omeprazole (as sodium) | 40-mg vial | Recipient | 24.00 | 24.00 | CRF p. 111 |
Ondansetrol (as hydrochloride), 2 mg/ml | 1-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ondansetron (as hydrochloride), 4 mg | 30-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Oxycodone hydrochloride, 5 mg | 56-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Oxycodone hydrochloride, 10 mg | 56-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Pabrinex vitamin B substances with ascorbic acid, 250 mg/10 ml | 2 × 5-ml ampoule | Recipient | 2.00 | 2.00 | CRF p. 111 |
Packed red blood cells | 274-ml bag | Recipient | 61.00 | 61.00 | CRF p. 111 |
Paracetamol, 500 mg | 32-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Paracetamol, 1 g | 10 mg/ml 100-ml vial | Recipient | 28.00 | 28.00 | CRF p. 111 |
Peppermint water | 100-ml solution | Recipient | 1.00 | 1.00 | CRF p. 111 |
Perindopril erbumine, 4 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Phenoxymethylpenicillin (as potassium), 250 mg | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Phosphate | 500-ml bottle | Recipient | 1.00 | 1.00 | CRF p. 111 |
Piperacillin (as sodium), 4 g; and tazobactam (as sodium), 500 mg (Tazocin) | 4.5-g vial | Recipient | 59.00 | 59.00 | CRF p. 111 |
Platelets | 250-ml bag | Recipient | 134.00 | 134.00 | CRF p. 111 |
Posaconazole, 100 mg | 96-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Potassium bicarbonate, 400 mg; and potassium chloride, 600 mg (Sando-K) | 20 tablets | Recipient | 2.00 | 2.00 | CRF p. 111 |
Potassium chloride, 150 mg/ml | 10-ml ampoule | Recipient | 14.00 | 14.00 | CRF p. 111 |
Pravastatin sodium, 10 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Pravastatin sodium, 20 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Pravastatin sodium, 40 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Prednisolone, 5 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Pregabalin, 25 mg | 56-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Pregabalin, 50 mg | 84-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Pregabalin, 75 g | 56-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Pregabalin, 100 mg | 84-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Prochlorperazine maleate, 3 mg | 5 × 10-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Propofol, 5 mg/ml | 20-ml ampoule | Recipient | 2.00 | 2.00 | CRF p. 111 |
Propofol, 10 mg/ml | 20-ml ampoule | Recipient | 6.00 | 6.00 | CRF p. 111 |
Propofol, 10 mg/ml | 50-ml pre-filled disposable injection | Recipient | 3.00 | 3.00 | CRF p. 111 |
Ramipril, 2.5 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ramipril, 5 mg | 28-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ranitidine (as hydrochloride), 25 mg/ml | 2-ml ampoule | Recipient | 6.00 | 6.00 | CRF p. 111 |
Ranitidine (as hydrochloride), 150 mg | 60-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ranitidine (as hydrochloride), 300 mg | 30-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Remifentanil (as hydrochloride) | 5-mg vial | Recipient | 3.00 | 3.00 | CRF p. 111 |
Risperidone, 500 µg | 20-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Risperidone, 2 mg | 60-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Salbutamol (as sulfate), 2.5 mg/2.5 ml | 20-unit dose nebuliser | Recipient | 6.00 | 6.00 | CRF p. 111 |
Salbutamol (as sulfate), 200 µg | 100-dose unit inhaler | Recipient | 1.00 | 1.00 | CRF p. 111 |
Sennoside B (as sennosides), 7.5 mg | 60-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Sildenafil (as citrate), 25 mg | 4-tablet pack | Recipient | 7.00 | 7.00 | CRF p. 111 |
Sodium chloride, 0.9% | 20 × 2.5-ml spray | Recipient | 9.00 | 9.00 | CRF p. 111 |
Sodium chloride, 600 mg | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Sodium cromoglycate, 5 mg/dose | 112-unit dose inhaler | Recipient | 1.00 | 1.00 | CRF p. 111 |
Sodium dihydrogen phosphate anhydrous, 1.936 g | 100-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Sodium valproate, 200 mg | 100-tablet pack | Recipient | 13.00 | 13.00 | CRF p. 111 |
Strepsils | 24-lozenge pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Sulfamethoxazole, 400 mg; and trimethoprim, 80 mg (co-trimoxazole) | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Tadalafil, 20 mg | 8-tablet pack | Recipient | 4.00 | 4.00 | CRF p. 111 |
Tamsulosin hydrochloride, 400 µg | 30-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
T.E.D. compression socks/hose (knee length) | Stocking | Recipient | 1.00 | 1.00 | CRF p. 111 |
Teicoplanin | 400-mg vial | Recipient | 21.00 | 21.00 | CRF p. 111 |
Theophylline (Uniphyllin), 200 mg | 56-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Thiamine hydrochloride, 100 mg | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Tiotropium (as bromide), 18 µg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Tobramycin, 60 mg/ml | 56 × 5 ml–300 mg unit | Recipient | 11.00 | 11.00 | CRF p. 111 |
Tobramycin, 75 mg/ml | 56 × 4-ml nebuliser | Recipient | 1.00 | 1.00 | CRF p. 111 |
Tramadol hydrochloride, 50 mg | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Tramadol hydrochloride, 50 mg | 60-capsule pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Tramadol hydrochloride, 100 mg | 60-capsule pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Ursodeoxycholic acid, 150 mg | 60-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Ursodeoxycholic acid, 300 mg | 60-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Valaciclovir (as hydrochloride), 500 mg | 42-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Valganciclovir (as hydrochloride), 450 mg | 60-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Vancomycin (as hydrochloride) | 1-g vial | Recipient | 2.00 | 2.00 | CRF p. 111 |
Vitamin B compound strong | 28-tablet pack | Recipient | 2.00 | 2.00 | CRF p. 111 |
Vitamins A, D and E | 30-capsule pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Multivitamins | 100-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Voriconazole, 200 mg | 28-tablet pack | Recipient | 3.00 | 3.00 | CRF p. 111 |
Warfarin sodium, 3 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
Water for injections | 5-ml ampoule | Recipient | 1.00 | 1.00 | CRF p. 111 |
Zopiclone, 3.75 mg | 28-tablet pack | Recipient | 1.00 | 1.00 | CRF p. 111 |
CO2, carbon dioxide; N2, nitrogen; ODA, operating department assistant.
- NHS resource use - An observational study of Donor Ex Vivo Lung Perfusion in UK ...NHS resource use - An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK
- Profile neighbors for GEO Profiles (Select 131485909) (199)GEO Profiles
Your browsing activity is empty.
Activity recording is turned off.
See more...